Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
Jan‐Niklas Eckardt(Klinik und Poliklinik für Psychotherapie und Psychosomatik), Christian Thiede(University Hospital Carl Gustav Carus), Hermann Einsele(Universitätsklinikum Würzburg), Gerhard Ehninger(University Hospital Carl Gustav Carus), Markus Schaich(Rems-Murr-Klinikum), Uta Oelschlägel(University Hospital Carl Gustav Carus), Sebastian Scholl(Jena University Hospital), Wolfgang E. Berdel(University Hospital Münster), Björn Steffen(Goethe University Frankfurt), Christoph Röllig(University Hospital Carl Gustav Carus), Martin Bornhäuser(Technische Universität Dresden), Carsten Müller‐Tidow(Heidelberg University), Claudia D. Baldus(University Hospital Schleswig-Holstein), Andreas Hochhaus(Jena University Hospital), Zdeněk Ráčil(Masaryk University), Jan Moritz Middeke(Fresenius (Germany)), Tim H. Brümmendorf(National University Cancer Institute, Singapore), A. Petzold(Center for Systems Biology Dresden), Andreas Neubauer(RWTH Aachen University), Andreas Dahl(Center for Systems Biology Dresden), Regina Herbst(Klinikum Chemnitz), Jiřı́ Mayer(Masaryk University), Mathias Hänel(Klinikum Chemnitz), Volker Kunzmann(University of Würzburg), Christoph Schliemann(University Hospital Münster), Andreas Burchert(Philipps University of Marburg), Ulrich Kaiser(St. Bernward Krankenhaus), Maher Hanoun(Essen University Hospital), Uwe Platzbecker(National Center for Tumor Diseases), Stefan W. Krause(Universitätsklinikum Erlangen), Hubert Serve(Goethe University Frankfurt), Tim Sauer(Heidelberg University), Martina Crysandt(RWTH Aachen University), Martin Kaufmann(Robert Bosch Hospital), Kerstin Schäfer‐Eckart(Nuremberg Hospital), Johannes Schetelig(University Hospital Carl Gustav Carus), Ralph Naumann(University of Siegen), Sebastian Stasik
Cited by 14
Related Papers
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
|Leukemia|2022|3.8k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k